Tego Science, Inc.
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2001-03-20
- Employees
- 42
- Market Cap
- -
- Website
- http://www.tegoscience.com
Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Safety Study of TPX-121 on Nasolabial Folds
- Conditions
- Nasolabial Fold, Hypoplastic
- Interventions
- Biological: TPX-115(allogeneic fibroblasts)
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Tego Science, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT06533540
- Locations
- 🇰🇷
Kyungpook National University, School of Medicine, Daegu, Jung-gu, Korea, Republic of
A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear
- Conditions
- Partial Thickness Rotator Cuff Tear
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Tego Science, Inc.
- Target Recruit Count
- 166
- Registration Number
- NCT06414005
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
Safety and Efficacy Study of TPX-105 for Correction of Nasojugal Groove
- Conditions
- Tear Trough Eyelid Deformity
- First Posted Date
- 2024-01-09
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- Tego Science, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06197789
- Locations
- 🇰🇷
Soonchunhyang University Hospital Bucheon, Bucheon, Korea, Republic of
🇰🇷Kyungpook National University Hospital, Daegu, Korea, Republic of
🇰🇷The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul, Korea, Republic of
Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear
- Conditions
- Rotator Cuff Injuries
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Tego Science, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT04470167
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
A Phase I/III Clinical Study of TPX-114 for the Treatment of Full-Thickness Rotator Cuff Tear
- Conditions
- Rotator Cuff Injuries
- First Posted Date
- 2018-09-12
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Tego Science, Inc.
- Target Recruit Count
- 93
- Registration Number
- NCT03668028
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of